Trial intelligence / Profile preview

EHSG-KF vs split-thickness skin grafts in pediatric deep dermal and full thickness burns

2017-002461-21Phase 2Active

Sponsor
CUTISS
Start
Sep 2017
Modality
Cell Therapies
Countries
1
01

Overview

Phase 2, randomised trial of denovoSkin in burn injury (2 arms), sponsored by CUTISS. Started Sep 2017; status: active.

02

Drugs

denovoSkin
03

Conditions

burn injury

Beyond the preview

Go deeper on 2017-002461-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002461-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call